Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 141 | Ituxredi | Authorised | rituximab | Lymphoma, Non-Hodgkin;Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid | Reddy Holding GmbH | 26-07-2024 |
| 142 | Filgrastim Hexal | Authorised | filgrastim | Hematopoietic Stem Cell Transplantation;Cancer | Hexal AG | 24-05-2018 |
| 143 | Zessly | Authorised | infliximab | Arthritis, Psoriatic;Psoriasis;Crohn Disease;Arthritis, Rheumatoid;Colitis, Ulcerative;Spondylitis, Ankylosing | Sandoz GmbH | 18-05-2018 |
| 144 | Ovaleap | Authorised | follitropin alfa | Anovulation | Theramex Ireland Limited | 16-05-2018 |
| 145 | Pelgraz | Authorised | pegfilgrastim | Accord Healthcare S.L.U. | 26-10-2018 | |
| 146 | Nepexto | Authorised | etanercept | Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Arthritis, Psoriatic;Spondylarthropathies;Spondylitis, Ankylosing;Psoriasis | Biosimilar Collaborations Ireland Limited | 04-06-2020 |
| 147 | Kauliv | Authorised | teriparatide | Osteoporosis;Osteoporosis, Postmenopausal | Strides Pharma (Cyprus) Limited | 18-07-2022 |
| 148 | Tevagrastim | Authorised | filgrastim | Hematopoietic Stem Cell Transplantation;Cancer | Teva GmbH | 31-05-2018 |
| 149 | Ratiograstim | Authorised | filgrastim | Hematopoietic Stem Cell Transplantation;Cancer | Ratiopharm GmbH | 31-05-2018 |
| 150 | Ximluci | Authorised | ranibizumab | Wet Macular Degeneration;Macular Edema;Diabetic Retinopathy;Diabetes Complications | STADA Arzneimittel AG | 14-09-2022 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.